IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v626y2024i7997d10.1038_s41586-023-06947-z.html
   My bibliography  Save this article

Structures, functions and adaptations of the human LINE-1 ORF2 protein

Author

Listed:
  • Eric T. Baldwin

    (ROME Therapeutics)

  • Trevor van Eeuwen

    (The Rockefeller University)

  • David Hoyos

    (Memorial Sloan Kettering Cancer Center)

  • Arthur Zalevsky

    (Department of Bioengineering and Therapeutic Sciences University of California, San Francisco
    University of California, San Francisco
    University of California, San Francisco)

  • Egor P. Tchesnokov

    (University of Alberta)

  • Roberto Sánchez

    (ROME Therapeutics)

  • Bryant D. Miller

    (Dana Farber Cancer Institute and Harvard Medical School)

  • Luciano H. Di Stefano

    (University Medical Center Groningen)

  • Francesc Xavier Ruiz

    (Rutgers University)

  • Matthew Hancock

    (Department of Bioengineering and Therapeutic Sciences University of California, San Francisco
    University of California, San Francisco
    University of California, San Francisco)

  • Esin Işik

    (Dana Farber Cancer Institute and Harvard Medical School)

  • Carlos Mendez-Dorantes

    (Dana Farber Cancer Institute and Harvard Medical School)

  • Thomas Walpole

    (Chesterford Research Park)

  • Charles Nichols

    (Chesterford Research Park)

  • Paul Wan

    (Chesterford Research Park)

  • Kirsi Riento

    (Chesterford Research Park)

  • Rowan Halls-Kass

    (Chesterford Research Park)

  • Martin Augustin

    (Proteros Biostructures GmbH, Martinsried)

  • Alfred Lammens

    (Proteros Biostructures GmbH, Martinsried)

  • Anja Jestel

    (Proteros Biostructures GmbH, Martinsried)

  • Paula Upla

    (The Rockefeller University)

  • Kera Xibinaku

    (Whitehead Institute for Biomedical Research)

  • Samantha Congreve

    (Whitehead Institute for Biomedical Research)

  • Maximiliaan Hennink

    (Whitehead Institute for Biomedical Research)

  • Kacper B. Rogala

    (Stanford University School of Medicine
    Stanford University School of Medicine
    Stanford University School of Medicine)

  • Anna M. Schneider

    (Max Planck Institute for Biology)

  • Jennifer E. Fairman

    (Johns Hopkins University School of Medicine)

  • Shawn M. Christensen

    (University of Texas at Arlington)

  • Brian Desrosiers

    (ROME Therapeutics)

  • Gregory S. Bisacchi

    (ROME Therapeutics)

  • Oliver L. Saunders

    (ROME Therapeutics)

  • Nafeeza Hafeez

    (ROME Therapeutics)

  • Wenyan Miao

    (ROME Therapeutics)

  • Rosana Kapeller

    (ROME Therapeutics)

  • Dennis M. Zaller

    (ROME Therapeutics)

  • Andrej Sali

    (Department of Bioengineering and Therapeutic Sciences University of California, San Francisco
    University of California, San Francisco
    University of California, San Francisco)

  • Oliver Weichenrieder

    (Max Planck Institute for Biology)

  • Kathleen H. Burns

    (Dana Farber Cancer Institute and Harvard Medical School)

  • Matthias Götte

    (University of Alberta)

  • Michael P. Rout

    (The Rockefeller University)

  • Eddy Arnold

    (Rutgers University)

  • Benjamin D. Greenbaum

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Donna L. Romero

    (ROME Therapeutics)

  • John LaCava

    (The Rockefeller University
    University Medical Center Groningen)

  • Martin S. Taylor

    (Massachusetts General Hospital and Harvard Medical School)

Abstract

The LINE-1 (L1) retrotransposon is an ancient genetic parasite that has written around one-third of the human genome through a ‘copy and paste’ mechanism catalysed by its multifunctional enzyme, open reading frame 2 protein (ORF2p)1. ORF2p reverse transcriptase (RT) and endonuclease activities have been implicated in the pathophysiology of cancer2,3, autoimmunity4,5 and ageing6,7, making ORF2p a potential therapeutic target. However, a lack of structural and mechanistic knowledge has hampered efforts to rationally exploit it. We report structures of the human ORF2p ‘core’ (residues 238–1061, including the RT domain) by X-ray crystallography and cryo-electron microscopy in several conformational states. Our analyses identified two previously undescribed folded domains, extensive contacts to RNA templates and associated adaptations that contribute to unique aspects of the L1 replication cycle. Computed integrative structural models of full-length ORF2p show a dynamic closed-ring conformation that appears to open during retrotransposition. We characterize ORF2p RT inhibition and reveal its underlying structural basis. Imaging and biochemistry show that non-canonical cytosolic ORF2p RT activity can produce RNA:DNA hybrids, activating innate immune signalling through cGAS/STING and resulting in interferon production6–8. In contrast to retroviral RTs, L1 RT is efficiently primed by short RNAs and hairpins, which probably explains cytosolic priming. Other biochemical activities including processivity, DNA-directed polymerization, non-templated base addition and template switching together allow us to propose a revised L1 insertion model. Finally, our evolutionary analysis demonstrates structural conservation between ORF2p and other RNA- and DNA-dependent polymerases. We therefore provide key mechanistic insights into L1 polymerization and insertion, shed light on the evolutionary history of L1 and enable rational drug development targeting L1.

Suggested Citation

  • Eric T. Baldwin & Trevor van Eeuwen & David Hoyos & Arthur Zalevsky & Egor P. Tchesnokov & Roberto Sánchez & Bryant D. Miller & Luciano H. Di Stefano & Francesc Xavier Ruiz & Matthew Hancock & Esin Iş, 2024. "Structures, functions and adaptations of the human LINE-1 ORF2 protein," Nature, Nature, vol. 626(7997), pages 194-206, February.
  • Handle: RePEc:nat:nature:v:626:y:2024:i:7997:d:10.1038_s41586-023-06947-z
    DOI: 10.1038/s41586-023-06947-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-06947-z
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-023-06947-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:626:y:2024:i:7997:d:10.1038_s41586-023-06947-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.